Published in Stroke on April 03, 2003
The role of lithium in the treatment of bipolar disorder: convergent evidence for neurotrophic effects as a unifying hypothesis. Bipolar Disord (2009) 1.62
Synergistic neuroprotective effects of lithium and valproic acid or other histone deacetylase inhibitors in neurons: roles of glycogen synthase kinase-3 inhibition. J Neurosci (2008) 1.58
Therapeutic potential of mood stabilizers lithium and valproic acid: beyond bipolar disorder. Pharmacol Rev (2013) 1.52
Molecular actions and therapeutic potential of lithium in preclinical and clinical studies of CNS disorders. Pharmacol Ther (2010) 1.39
Delayed administration of a single dose of lithium promotes recovery from AKI. J Am Soc Nephrol (2014) 1.28
Lithium reduces apoptosis and autophagy after neonatal hypoxia-ischemia. Cell Death Dis (2010) 1.19
GSK-3 as a Target for Lithium-Induced Neuroprotection Against Excitotoxicity in Neuronal Cultures and Animal Models of Ischemic Stroke. Front Mol Neurosci (2011) 1.14
Lithium-mediated long-term neuroprotection in neonatal rat hypoxia-ischemia is associated with antiinflammatory effects and enhanced proliferation and survival of neural stem/progenitor cells. J Cereb Blood Flow Metab (2011) 1.14
In search of the Holy Grail for the treatment of neurodegenerative disorders: has a simple cation been overlooked? Biol Psychiatry (2007) 1.10
Protective effects of repetitive transcranial magnetic stimulation in a rat model of transient cerebral ischaemia: a microPET study. Eur J Nucl Med Mol Imaging (2010) 0.97
Functional MRI of delayed chronic lithium treatment in rat focal cerebral ischemia. Stroke (2008) 0.96
The neurotrophic and neuroprotective effects of psychotropic agents. Dialogues Clin Neurosci (2009) 0.95
Intracellular mechanisms of N-acylethanolamine-mediated neuroprotection in a rat model of stroke. Neuroscience (2009) 0.94
Beneficial effects of mood stabilizers lithium, valproate and lamotrigine in experimental stroke models. Acta Pharmacol Sin (2011) 0.93
Neuroprotective effects of psychotropic drugs in Huntington's disease. Int J Mol Sci (2013) 0.88
Lauroylethanolamide and linoleoylethanolamide improve functional outcome in a rodent model for stroke. Neurosci Lett (2011) 0.88
Neuroprotective action of lithium in disorders of the central nervous system. Zhong Nan Da Xue Xue Bao Yi Xue Ban (2011) 0.87
Lithium protects against toxic effects of cadmium in the rat testes. J Assist Reprod Genet (2010) 0.85
Treatment with antidepressants and lithium is associated with increased risk of treatment with antiparkinson drugs: a pharmacoepidemiological study. J Neurol Neurosurg Psychiatry (2006) 0.85
Therapeutic targeting of GSK3β enhances the Nrf2 antioxidant response and confers hepatic cytoprotection in hepatitis C. Gut (2014) 0.84
Lithium and autophagy. ACS Chem Neurosci (2014) 0.82
Therapeutic benefits of delayed lithium administration in the neonatal rat after cerebral hypoxia-ischemia. PLoS One (2014) 0.81
Neuroprotective effects of lithium treatment following hypoxic-ischemic brain injury in neonatal rats. Childs Nerv Syst (2011) 0.80
A modified suture technique produces consistent cerebral infarction in rats. Brain Res (2008) 0.80
Precise Characterization of the Penumbra Revealed by MRI: A Modified Photothrombotic Stroke Model Study. PLoS One (2016) 0.79
Dose-dependent protective effect of lithium chloride on retinal ganglion cells is interrelated with an upregulated intraretinal BDNF after optic nerve transection in adult rats. Int J Mol Sci (2014) 0.79
Transient filament occlusion of the middle cerebral artery in rats: does the reperfusion method matter 24 hours after perfusion? BMC Neurosci (2012) 0.78
Phosphorylation of tau protein over time in rats subjected to transient brain ischemia. Neural Regen Res (2013) 0.78
The amnesiac gene is involved in the regulation of thermal nociception in Drosophila melanogaster. J Neurogenet (2010) 0.78
Combination treatment with low-dose Niaspan and tissue plasminogen activator provides neuroprotection after embolic stroke in rats. J Neurol Sci (2011) 0.77
Early intervention in bipolar disorder, part II: therapeutics. Early Interv Psychiatry (2008) 0.76
Lithium treatment reduces brain injury induced by focal ischemia with partial reperfusion and the protective mechanisms dispute the importance of akt activity. Aging Dis (2012) 0.76
Repurposing psychiatric medicines to target activated microglia in anxious mild cognitive impairment and early Parkinson's disease. Am J Neurodegener Dis (2016) 0.76
Lithium-induced neuroprotection in stroke involves increased miR-124 expression, reduced RE1-silencing transcription factor abundance and decreased protein deubiquitination by GSK3β inhibition-independent pathways. J Cereb Blood Flow Metab (2016) 0.76
Effects of Acute Lithium Treatment on Brain Levels of Inflammatory Mediators in Poststroke Rats. Biomed Res Int (2015) 0.75
Lithium promotes DNA stability and survival of ischemic retinal neurocytes by upregulating DNA ligase IV. Cell Death Dis (2016) 0.75
A new look at an old drug: neuroprotective effects and therapeutic potentials of lithium salts. Neuropsychiatr Dis Treat (2016) 0.75
c-Jun N-terminal protein kinase (JNK) 2/3 is specifically activated by stress, mediating c-Jun activation, in the presence of constitutive JNK1 activity in cerebellar neurons. J Neurosci (2002) 1.59
Angiotensin AT2 receptor protects against cerebral ischemia-induced neuronal injury. FASEB J (2005) 1.54
c-Jun N-terminal kinases (JNKs) mediate pro-inflammatory actions of microglia. Glia (2005) 1.51
Angiotensin II and the fibroproliferative response to acute lung injury. Am J Physiol Lung Cell Mol Physiol (2003) 1.46
Lithium blocks the c-Jun stress response and protects neurons via its action on glycogen synthase kinase 3. Mol Cell Biol (2003) 1.41
Effects of early life stress on adult male aggression and hypothalamic vasopressin and serotonin. Eur J Neurosci (2006) 1.27
PPAR-gamma: therapeutic target for ischemic stroke. Trends Pharmacol Sci (2007) 1.20
Therapeutic window for use of hyperbaric oxygenation in focal transient ischemia in rats. Stroke (2004) 1.19
Chronic pretreatment with candesartan improves recovery from focal cerebral ischaemia in rats. J Hypertens (2003) 1.11
Circulating angiotensin converting enzyme activity is correlated with muscle strength. Med Sci Sports Exerc (2005) 1.05
Comparison between early and delayed systemic treatment with candesartan of rats after ischaemic stroke. J Hypertens (2007) 1.03
Prolactin prevents chronic stress-induced decrease of adult hippocampal neurogenesis and promotes neuronal fate. J Neurosci (2009) 1.02
Sustained blockade of brain AT1 receptors before and after focal cerebral ischemia alleviates neurologic deficits and reduces neuronal injury, apoptosis, and inflammatory responses in the rat. J Cereb Blood Flow Metab (2004) 1.02
Mice deficient for the ets transcription factor elk-1 show normal immune responses and mildly impaired neuronal gene activation. Mol Cell Biol (2004) 1.01
The intracerebral application of the PPARgamma-ligand pioglitazone confers neuroprotection against focal ischaemia in the rat brain. Eur J Neurosci (2005) 1.00
No association between Angiotensin Converting Enzyme (ACE) gene variation and endurance athlete status in Kenyans. Comp Biochem Physiol A Mol Integr Physiol (2005) 0.98
Effects of orally applied candesartan cilexetil on central responses to angiotensin II in conscious rats. J Hypertens (2002) 0.95
Peroxisome-proliferator-activated receptors gamma and peroxisome-proliferator-activated receptors beta/delta and the regulation of interleukin 1 receptor antagonist expression by pioglitazone in ischaemic brain. J Hypertens (2010) 0.93
The c-Jun N-terminal kinases in cerebral microglia: immunological functions in the brain. Biochem Pharmacol (2002) 0.93
Low inborn anxiety correlates with high intermale aggression: link to ACTH response and neuronal activation of the hypothalamic paraventricular nucleus. Horm Behav (2006) 0.93
Patient-assessed versus physician-assessed disease severity and outcome in patients with nonspecific pain associated with major depressive disorder. Prim Care Companion J Clin Psychiatry (2009) 0.92
Peroxisome proliferator-activated receptorsgamma (PPARgamma) differently modulate the interleukin-6 expression in the peri-infarct cortical tissue in the acute and delayed phases of cerebral ischaemia. Eur J Neurosci (2008) 0.91
Angiotensin II induces peroxisome proliferator-activated receptor gamma in PC12W cells via angiotensin type 2 receptor activation. J Neurochem (2005) 0.91
Neuronal c-Jun is required for successful axonal regeneration, but the effects of phosphorylation of its N-terminus are moderate. J Neurochem (2012) 0.89
Contribution of bradykinin and nitric oxide to AT2 receptor-mediated differentiation in PC12 W cells. J Neurochem (2003) 0.89
Acute blood pressure effects and chronic hypotensive action of calcimimetics in uremic rats. J Am Soc Nephrol (2006) 0.88
The JNK inhibitor D-JNKI-1 blocks apoptotic JNK signaling in brain mitochondria. Mol Cell Neurosci (2011) 0.85
Low-dose lithium combined with captopril prevents stroke and improves survival in salt-loaded, stroke-prone spontaneously hypertensive rats. J Hypertens (2005) 0.85
Increase in tumor size following intratumoral injection of immunostimulatory CpG-containing oligonucleotides in a rat glioma model. Cancer Immunol Immunother (2009) 0.83
Measurement of plasma endothelin-1 in experimental hypertension and in healthy subjects. Am J Hypertens (2003) 0.83
Treatment of rats with pioglitazone in the reperfusion phase of focal cerebral ischemia: a preclinical stroke trial. Exp Neurol (2012) 0.82
Effects of aliskiren on stroke in rats expressing human renin and angiotensinogen genes. PLoS One (2010) 0.82
Duloxetine treatment and glycemic controls in patients with diagnoses other than diabetic peripheral neuropathic pain: a meta-analysis. Curr Med Res Opin (2010) 0.81
ANG III induces expression of inducible transcription factors of AP-1 and Krox families in rat brain. Am J Physiol Regul Integr Comp Physiol (2005) 0.81
Predictors of relapse in a study of duloxetine treatment in patients with major depressive disorder. J Affect Disord (2008) 0.81
Prolactin induces MAPK signaling in neural progenitors without alleviating glucocorticoid-induced inhibition of in vitro neurogenesis. Cell Physiol Biochem (2009) 0.80
Bradykinin B1 and B2 receptors differentially regulate cardiac Na+-H+ exchanger, Na+-Ca2+ exchanger and Na+-HCO3- symporter. Eur J Pharmacol (2003) 0.79
Early postnatal depletion of NMDA receptor development affects behaviour and NMDA receptor expression until later adulthood in rats--a possible model for schizophrenia. Behav Brain Res (2009) 0.79
Short-term effects of exogenous angiotensin II on plasma fibrinolytic balance in normal subjects. Clin Exp Hypertens (2004) 0.78
Enhanced contractility of small blood vessels in JNK knockout mice. Eur J Pharm Sci (2006) 0.78
No correlation between circulating ACE activity and VO2max or mechanical efficiency in women. Eur J Appl Physiol (2006) 0.78
Effect of angiotensin AT2 receptor stimulation on vascular cyclic GMP production in normotensive Wistar Kyoto rats. Int J Biochem Cell Biol (2003) 0.78
Haplotype of growth hormone and angiotensin I-converting enzyme genes, serum angiotensin I-converting enzyme and ventricular growth: pathway inference in pharmacogenetics. Pharmacogenet Genomics (2007) 0.78
The serum angiotensin-converting enzyme and angiotensin II response to altered posture and acute exercise, and the influence of ACE genotype. Eur J Appl Physiol (2003) 0.78
Are biological actions of neurokinin A in the adult brain mediated by a cross-talk between the NK1 and NK2 receptors? Neuropharmacology (2012) 0.77
Tumor necrosis factor-alpha receptor 1 (p55) knockout only transiently decreases the activation of c-Jun and does not affect the survival of axotomized dopaminergic nigral neurons. Eur J Neurosci (2005) 0.76
Time course of improvement of different symptom clusters in patients with major depression and pain treated with duloxetine or placebo. Curr Med Res Opin (2011) 0.75
Role of neutral endopeptidase and angiotensin-converting enzyme in deoxycorticosterone acetate-salt hypertension. J Hypertens (2002) 0.75
Differential effect of acute angiotensin II type 1 receptor blockade on the vascular and adrenal response to exogenous angiotensin II in humans. Am J Hypertens (2003) 0.75
Omapatrilat: penetration across the blood-brain barrier and effects on ischaemic stroke in rats. Naunyn Schmiedebergs Arch Pharmacol (2015) 0.75
Lack of change in serum angiotensin-converting enzyme activity during the menstrual cycle. J Renin Angiotensin Aldosterone Syst (2006) 0.75